Shivam Bansal/LinkedIn
Aug 9, 2026, 02:08
Shivam Bansal: Targeting Chemotherapy-Induced Thrombocytopenia in Children with Romiplostim
Shivam Bansal, Pediatric Hematology-Oncology and BMT Consultant at TATA Medical Center, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in British Journal of Cancer, adding:
“Pleased to share that my DM (Pediatric Oncology) thesis got published in the prestigious British Journal of Cancer, one of the leading oncology journals of the world (Q1).
Grateful to Almighty, my family, mentors and the tiny, fearless warriors (my patients) along with their families!!”
Title: Romiplostim for chemotherapy induced thrombocytopenia in pediatric cancers
Authors: Shivam Bansal, Aditya Kumar Gupta, Jagdish Prasad Meena, Tushar Sehgal, Rachna Seth
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 29, 2026, 12:37Dan Milikovsky: Uncovering Cerebrovascular Injury in Sickle Cell Disease
-
Sep 29, 2026, 12:02Hajra Malik: Bridging Language Gaps in Hematology With AI
-
Sep 29, 2026, 11:57Joan Montaner: Can Blood Test Identify Intracerebral Hemorrhage Within Minutes?
-
Sep 29, 2026, 11:43From Years Without Answers to Life With Hemophilia Care – WFH
-
Sep 29, 2026, 11:32Sara Al Dallal: Transforming Hemophilia Care Across the Gulf
-
Sep 29, 2026, 11:21Richard Davis: Rapid Rescue in Massive Pulmonary Embolism
-
Sep 29, 2026, 11:14Nissan Brown: Every Step Counts for the Hemophilia Community
-
Sep 29, 2026, 11:03Zain Khalpey: SINGLE AF Adds New Evidence to the Anticoagulation Debate
-
Sep 29, 2026, 10:54How Does Haemophilia Affect Motor Development in Infants? – EAHAD